SGLT2i in CKD with high albuminuria: an observational real-world study

被引：0
|
作者：
Svensson, Maria K. [1 ]
Bodegard, Johan [2 ]
Thuresson, Marcus [3 ]
Ambery, Philip [2 ]
机构：
[1] Uppsala Univ, Uppsala, Sweden
[2] AstraZeneca, Gothenburg, Sweden
[3] Statisticon AB, Uppsala, Sweden
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
10.1093/ndt/gfae069.147
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
2638
引用
收藏
页数：2
相关论文
共 50 条
  • [1] SGLT2i in CKD with high albuminuria: an observational real-world study
    Svensson, Maria K.
    Bodegard, Johan
    Thuresson, Marcus
    Ambery, Philip
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I263 - I264
  • [2] SGLT2i Prescribers Among CKD Patients: Trends in Real-World Data (RWD)
    Stavas, Joseph
    Butler, Emily L.
    Abdelhadi, Jenna
    Zhang, Tancy C.
    Rubens, Lexie
    Irwin, Debra E.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 573 - 573
  • [3] Real world experience of SGLT2i in HFrEF patients
    Saharudin, S.
    Yen, C. H.
    Tan, S. L.
    Kaukiah, N. F.
    Yong, V. S.
    Liew, H. B.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 393
  • [4] High albuminuria in CKD: prevalence and characteristics in a real-world clinical setting
    Svensson, Maria K.
    Bodegard, Johan
    Thuresson, Marcus
    Ambery, Philip
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I950 - I950
  • [5] High albuminuria in CKD: prevalence and characteristics in a real-world clinical setting
    Svensson, Maria K.
    Bodegard, Johan
    Thuresson, Marcus
    Ambery, Philip
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [6] SGLT2I AS RENOPROTECTION TOOL IN CHILDREN WITH CKD
    Ivanov, Dmytro
    Ivanova, Mariia
    PEDIATRIC NEPHROLOGY, 2021, 36 (10) : 3325 - 3325
  • [7] Effect on Renal Function of SGLT2i Treatment in Hospitalized Patients with Type 2 Diabetes-A Real-World Study
    Bashkin, Amir
    Kruzel-Davila, Etty
    Tzfoni, Itai
    DIABETES, 2023, 72
  • [8] Combined treatment with SGLT2i and GLP1ra compared with SGLT2i or GLP1ra alone improves survival: a Real-World Registry
    Garcia Vega, D.
    Cinza-Sanjurjo, S.
    Eiras, S.
    Gonzalez-Juanatey, J. R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 591 - 591
  • [9] Metformin and SGLT2i as First-line Combination Therapy in Type 2 Diabetes: A Real-world Study With a Focus on Ethnicity
    Anson, Matthew
    Zhao, Sizheng Steven
    Essa, Hani
    Austin, Philip
    Ibarburu, Gema Hernandez
    Lip, Gregory Y. H.
    Alam, Uazman
    CLINICAL THERAPEUTICS, 2023, 45 (12) : 1259 - 1265
  • [10] Comparing treatment strategies for heart failure: a real-world analysis of adding ARNI or SGLT2i to older GDMT
    Amornritvanich, P.
    Numthavaj, P.
    Anothaisintawee, T.
    Tansawet, A.
    Thakkinstian, A.
    EUROPEAN HEART JOURNAL, 2024, 45
12345